In some studies, the expression level of SATB1 correlated with cancer progression and was suggested to be an useful prognostic marker in breast cancer, laryngeal squamous cell carcinoma, cutaneous melanoma, glioma, gastric, and hepatocellular cancer [3, 5–7, 10]. This evidence concerns the gene SATB1 and cancer.